Drug Pipeline

nab-Sirolimus Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06494150 Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO) Low Grade Ovarian Serous Adenocarcinoma Recruiting
NCT07104331 SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic… Epithelioid Hemangioendothelioma (EHE) Recruiting
Phase 1
NCT06308419 A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas… Leiomyosarcoma Recruiting
Sponsors Running nab-Sirolimus Trials
M.D. Anderson Cancer Center (1) University of Oklahoma (1) Sarcoma Alliance for Research through Collaboration (1)
Disease Areas
Sarcoma (1)
Get alerts when nab-Sirolimus trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free